Next Phase Newsletter

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

Life Science Nation’s RESI Boston is just around the corner, and excitement is building for the Innovator’s Pitch Challenge (IPC). This year, we are thrilled to feature 56 innovative startups across 14 sessions, each dedicated to a specific sector or subsector within the life sciences.

The LSN team has been hard at work recruiting a panel of active investors and industry experts to serve as judges for the pitches. These judges have been invited to participate based on their experience, investment interests, and areas of expertise, ensuring that each session is tailored to the right audience.

We are excited to introduce the esteemed IPC pitch judges who will be lending their insights and expertise at RESI Boston. Their participation adds immense value to the event, offering startups the chance to receive invaluable feedback and explore new avenues for funding their ideas.

Below is a list of IPC pitch judges at RESI Boston:

Featured RESI Boston IPC Pitch Judges
Chris Aleong Vice President BioIdeations	Peter Alff Senior Venture Partner Orange Grove Bio	Anjan Aralihalli Member of Board of Directors Muscular Dystrophy Association	Giulia Balconi Investor Adjuvant Capital
Michael Benezra Managing Partner & Founder Erez Capital	Carmelida Capaldi Innovation Project Manager Chiesi	James Carroll Managing Director for Life Science Investments Wharton Alumni Angels	Doug Cary Founder and Principal Meritage Technologies
Jeffrey Champagne Screening Committee Boston Harbor Angels	Shailesh Chavan Managing Partner Transatlantic Life Science Venture	Nicolas Cindric Partner Yahara Ventures	David Fogel Member of Screening & Due Diligence Committees Mass Medical Angels
Emily Gaudiano Investment Associate SV Health Investors	Henry Huang Head, Strategy Marketing Autobio Venture Capital	Brendan Hussey Vice President JLS Fund	Ehsan Jabbarzadeh Venture Partner IAG Capital Partners
Jennifer Jordan Venture Partner iGlobe Partners	Jeff Knox Senior Associate Innospark Ventures	Uplaksh KumarForesite Capital	Claire Leurent Managing Director AbbVie Ventures
Carlos Medina Senior Associate SIC Venture Studio	Jose Navarro Scientific Director & Partner quadraScope Venture Fund	Kim Nearing Venture Partner BioVeda China Fund (BVCF)	Shinji Okitsu External Immunology Lead North America and China Sanofi
Aaron Ray Partner 5 Horizons Capital	Joe Rogers Venture Partner, Digital Health Tenmile	James Simmons Associate Director Business Development Kowa Research Institute, Inc.	Manbir Singh Program Manager Biomedical Advanced R&D Authority (BARDA)
Adam Steinert CTO Yahara Ventures	Wei Tao Board Director & Chair, Bio/Genomics Life Science Angels	Mike Thomas Managing Partner Bold Brain Capital	Natalia Ulyanova Director, Business Development, Oncology Astellas Pharma
Mark Vreeke Co-Founder Chemical Angel Network	Christopher Whitfield Partner Syridex Bio	Hong Xin Senior Director, External Innovation, Search & Evaluation Johnson & Johnson Innovation	Hao Xing Associate MPM Capital
Chris Yoo General Partner and Managing Director Xcellerant Ventures	Join RESI Boston to Meet More Investors or Investor Judges

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

The Life Science Nation (LSN) team is gearing up for the highly anticipated RESI Boston conference, set to take place from September 25-27, 2024, at the Westin Copley Place Hotel. This event promises to be a cornerstone for early-stage life science and healthcare investment, offering attendees knowledge through a curated program of 7 insightful investor panels.

RESI Boston will kick off with an in-person event on September 25, providing face-to-face networking and engagement opportunities. The conference will then continue with virtual partnering sessions on September 26-27, allowing participants to extend their interactions and explore new opportunities from anywhere in the world.

The event will bring together a diverse lineup of panelists from various investment groups, each specializing in critical sectors such as Partnering with Pharma, Angel Investors, Digital Health, Early-stage Therapeutics, Diagnostics, Family Offices, and AI in Healthcare. These industry leaders will offer their unique perspectives on investment strategies, emerging industry trends, and the evolving startup ecosystem.

At the heart of RESI Boston is the goal of fostering meaningful dialogue between investors and fundraising CEOs. The panels are designed to provide actionable insights on capital-raising strategies and partnership acquisition, equipping companies with the tools they need to navigate the complex fundraising landscape successfully. For founders and CEOs, these panels represent an invaluable opportunity to connect directly with investors, broaden their networks, and gain the critical insights needed to drive their businesses forward.

Join these panelists at RESI Boston:

John Abeles General Partner Northlea Partners	Wayne Boulais Co-Founder & Partner Tensility Venture Partners	Nat Brinn Partner VC23	Carter Caldwell Program Director, Penn Medicine Co-Investment Program Penn Center for Innovation (PCI)
Ian Chiang Partner Flare Capital Partners	Bruce Cohen Venture Partner Xeraya Capital	Fabrizio Conicella Head COI&C, Center of Open Innovation & Competence Chiesi	Neel Desai Executive Director, BD & Licensing Biogen
Ronald Dorenbos VP, Business Development Evotec	David Fogel Angel Investor Mass Medical Angels	Chris Garabedian CEO Xontogeny	Allan Gobbs Managing Partner ATEM Capital
Jill Goldstein Senior Associate Vida Ventures	Shahram Hejazi Partner BioAdvance	Deborah Hemingway Managing Partner Ecphora Capital	Tomoko Ishikura Partner Kicker Ventures
Jun Jeon Principal Khosla Ventures	Priyanka Kanal Associate McKesson Ventures	Kristin King-Jankiewicz Member & Head of Group Management Boston Harbor Angels	Michael Langer Founder & Managing Partner T.Rx Capital
Claire Leurent Managing Director AbbVie Ventures	Fiona Mack VP, Head Co.Lab Cambridge US Bayer	Hannah Mamuszka Managing Partner 10Edison Capital	Andrew Merken Sharholder Polsinelli PC
James Murray Partner ExSight Ventures	Gauri Nair Senior Director Business Development AbCellera	Soyoung Park General Partner 804 Venture Partners	John Parker Founder and Managing Director Springhood Ventures
John Pennett Angel Investor Mid Atlantic Bio Angels	Garrett Peterson Chief Revenue Officer Yahara Ventures	David Prim Senior Associate Broadview Ventures	Asli Sahin Director, Search & Evaluation, Neuroscience AbbVie
Squire Servance Founder & Managing Partner Syridex Bio	Sunil Shah CEO o2h Ventures	Michka Sharpe Senior Associate BrightEdge	Elia Stupka Managing Director (Rome/Singapore) Angelini Ventures
Ashim Subedee Director, Catalyst Office Biomedical Advanced R&D Authority (BARDA)	Mike Thomas Managing Partner Bold Brain Capital	Joshi Venugopal Head of Region Europe, SVP Novartis

By Faith Patenaude, Investor Research Analyst, LSN

The Family Office Investor Fireside Chat – Strategies for Family Office Investments offers a valuable exploration of investment strategies from a panel of prominent family office investors. Moderated by Claire Jeong of Life Science Nation, this engaging discussion features insights from Katherine Hill Ritchie of Private Capital Investments, Ron Paliwoda of the Paliwoda Group, Shubhra Jain of Tarsadia Investments, and Bryan Grulke of Volcano Capital.

The panelists delve into their approaches to early-stage investments, outline their investment strategies, and discuss the distinct advantages and considerations of working with family office investors compared to traditional venture capital. Discover these expert perspectives by viewing the recorded webinar.

The discussion on family office investments continues at the upcoming RESI Boston conference. This event will feature a dedicated Family Office investor panel, offering further insights into their perspectives on early-stage investments, investment strategies, and the implications of partnering with family office investors versus traditional VCs. Additionally, RESI will host the invite-only Global Family Office Bioforum Luncheon, providing a unique opportunity to connect with key figures in family office investment.

By Greg Mannix, VP, EMEA Business Development, LSN

Limited Openings for 1 Medtech and 1 Therapeutics Pitch at RESI Boston!

Apply to Pitch at RESI Boston 2024

Early-stage entrepreneurs in the life sciences have an opportunity to showcase their innovations at the upcoming RESI conferences. Although the RESI Boston Innovator’s Pitch Challenge is close to fully booked, you can still apply to pitch at RESI London on Wednesday, December 4 and RESI JPM in San Francisco on Tuesday, January 14.

• Apply to Pitch at RESI London 2024
• Apply to Pitch at RESI JPM 2025

RESI’s Innovator’s Pitch Challenge (IPC) offers a unique advantage compared to typical company presentations. Unlike other conferences, companies pitch to a dedicated team of coordinated investors who are actively engaged, providing interactive questions and feedback throughout the process.

 Participants in the IPC will benefit from:

• RESI conference registrations with 1-to-1 partnering opportunities to arrange meetings with over a hundred attending investors and licensing partners.
• Exhibit a poster in the Innovator’s Pitch Exhibition Hall.
• The chance to win complimentary RESI registration for future conferences.

This is a prime opportunity to gain significant exposure, connect with key industry figures, and advance your venture. Don’t miss out on this chance to make a meaningful impact!

Submit your application soon to secure your spot!

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

Get ready for a showcase of groundbreaking ideas at the upcoming RESI Boston 2024! The Innovator’s Pitch Challenge (IPC) will feature 11 dynamic sessions where finalist companies present their cutting-edge innovations to a panel of distinguished investors and industry experts. In addition to their live pitches, each finalist will display their technology in the RESI exhibit hall, providing an excellent opportunity for attendees to delve deeper into their visionary projects.

Meet the Innovator’s Pitch Challenge Finalists

Every RESI attendee will be given five pieces of “RESI Cash” to cast their votes for the most promising companies. The three companies with the most votes will be announced at the event’s close, earning them not only a coveted prize but also a feature in the RESI newsletter. This challenge offers startups a unique platform to gain visibility, actively fundraise, and network with conference attendees—many of whom are potential investors.

If you’re planning to attend RESI Boston, don’t miss the chance to witness these innovative pitches and explore the posterboards in the exhibit hall. Want to see these presentations up close and connect with the startups one-on-one? Make sure to register for the event here.